HIV, Human immunodeficiency virus – Communicable Diseases Research

Meeting Summary: Global Vaccine and Immunization Research Forum, 2021

article

Published on 2023-03-102024-09-05
Journal: Vaccine [Category] update2024,

A case of Rowell syndrome with excellent improvement following anifrolumab

Case Report

Published on 2022-11-132024-09-04
Journal: JAAD Case Reports [Category] 대상포진,

The constellation of cholesterol-dependent processes associated with SARS-CoV-2 infection

Review

Published on 2022-05-022023-06-15
Journal: Progress in lipid research [Category] COVID19(2023년), MERS, SARS,

[키워드] ACE2, angiotensin converting enzyme 2 CARC and CRAC, cholesterol-recognition motifs CDx, methyl-β-cyclodextrin cholesterol cholesterol metabolism Cholesterol-rich lipid domains CMV, human cytomegalovirus CoV, coronavirus COVID-19 comorbidities DMVs, double-membrane vesicles HCV, hepatitis C virus HDL, high-density lipoprotein HIV, Human immunodeficiency virus HMGCR, 3-hydroxy-3-methy-lglutaryl coenzyme A reductase IAV, influenza A virus IL, interleukin LDL, low-density lipoprotein MERS, middle-East respiratory syndrome New therapeutic strategies for COVID-19 SARS, Severe acute respiratory syndrome severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) SRE-1, sterol regulatory element 1 SREBP, sterol regulatory element binding protein statins TMPRSS2, Transmembrane Protease Serine 2 virus infection
[DOI] 10.1016/j.plipres.2022.101166 PMC 바로가기 [Article Type] Review

Recent advances in passive immunotherapies for COVID-19: The Evidence-Based approaches and clinical trials

Review

Published on 2022-04-212022-10-04
Journal: International immunopharmacology [Category] COVID19(2023년), SARS, 변종, 임상, 치료제,

[키워드] 2019-nCoV, 2019 novel coronavirus Abstract accompany ACE-2, Angiotensin-Converting Enzyme-2 acute respiratory disease syndrome acute respiratory distress acute respiratory syndrome ADE, Antibody-dependent enhancement adverse effect AE_(s), Adverse effect_(s) AEs approach ARDS ARDS, acute respiratory distress syndrome CAR, Chimeric antigen receptor Cellular Immunotherapy clinical trial Community complementary Convalescent plasma (CP) therapy coronavirus COVID-19 COVID-19 vaccination COVID-19 vaccines COVID-19, Coronavirus disease 2019 CPT, Convalescent plasma therapy CRP, C-reactive protein CRS, Cytokine release syndrome CT_(s), Clinical trial_(s) Cytokine storm Efficacy effort emerging disease epidemiological ESR, Erythrocyte sedimentation rate FCR, Fc receptor FDA, Food and Drug Administration global pandemic GM-CSF, granulocyte-macrophage colony-stimulating factor group GVHD, Graft-versus-host disease HBV, Hepatitis B HCV, Hepatitis C highlight HIV, Human immunodeficiency virus HLH, Hemophagocytic lymphohistiocytosis Human I.V., Intravenous IBD, Inflammatory bowel disease IFN, interferon IGG, immunoglobulin g immunomodulation Immunotherapy Inflammation inhibiting International investigated IVIG, intravenous immunoglobulin LAG-3, Lymphocyte-activation gene 3 LDH, lactate dehydrogenase mAb_(s), Monoclonal antibody_(s) MERS-COV, Middle East respiratory syndrome-corona virus monoclonal antibody MV, Mechanical ventilation Passive Passive immunotherapy PCR, polymerase chain reaction PD-1, Programmed cell death protein-1 platform RA, Rheumatoid arthritis RBD, receptor-binding domain recent reduced SARS-CoV-2 SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2 syndrome TIM-3, T cell immunoglobulin domain and mucin domain-3 TNF, Tumor Necrosis Factor TRALI, Transfusion-related acute lung injury treating COVID-19 patient Treatment Vaccine variants of SARS-CoV-2 VEGF, Vascular endothelial growth factor Viral load viral neutralization
[DOI] 10.1016/j.intimp.2022.108786 PMC 바로가기 [Article Type] Review

Zoster meningitis in an immunocompetent young patient post first dose of BNT162b2 mRNA COVID-19 vaccine, a case report

Case Report

Published on 2022-02-122024-09-04
Journal: IDCases [Category] 대상포진,

[키워드] COVID-19 CSF, Cerebrospinal fluid CT, Computed tomography DNA, Deoxyribonucleic acid GP, general practitioner HIV, Human immunodeficiency virus Meningitis mRNA mRNA, messenger Ribonucleic Acid PCR, polymerase chain reaction RNA, Ribonucleic acid RT-PCR, reverse transcriptase polymerase chain reaction Vaccine VZV, Varicella zoster virus WBC, White blood cell count Zoster
[DOI] 10.1016/j.idcr.2022.e01452 PMC 바로가기 [Article Type] Case Report

HPV prevention and control – The way forward

Article

Published on 2022-01-202023-06-18
Journal: Preventive medicine [Category] MERS, SARS,

[키워드] AI, artificial intelligence AIDS, acquired immunodeficiency syndrome cervical cancer COVID-19 pandemic COVID-19, Coronavirus disease of 2019 Elimination GACVS, Global Advisory Committee on Vaccine Safety GAVI, GAVI, the Vaccine Alliance HIC, High income countries HIV, Human immunodeficiency virus HPV HPV, Human Papillomavirus LMIC, low- and middle-income countries NAAT, Nucleic acid amplification test PCR, polymerase chain reaction Prevention and control SARS-COV-2, severe acute respiratory syndrome coronavirus-2 Screening Treatment UNICEF, United Nations Children's fund vaccination VIA, Visual inspection with acetic acid WHO, World Health Organization WLWHIV, Women living with HIV
[DOI] 10.1016/j.ypmed.2022.106960 PMC 바로가기 [Article Type] Article

Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial

5 개의 면역 저하 환자 및 전향 적 개방형 임상 시험에서 건강한 대조군에서 SARS-COV-2에 대한 mRNA BNT162B2 백신의 안전성 및 효능

Research paper

Published on 2021-11-302022-08-13
Journal: EBioMedicine [Category] MERS, SARS, 임상,

[키워드] Adverse adverse events Adverse reaction Allogeneic allogeneic hematopoietic stem cell transplantation Antibody titre antibody titres BNT162b2 BNT162b2 mRNA BNT162b2 mRNA vaccination CAR T, Chimeric antigen receptor T CAR-T Cell Cell therapy certain immunocompromised patient groups chronic lymphocytic leukemia clinical trial clinical trials CLL CLL, Chronic lymphocytic leukemia Control controls Council COVID-19, Coronavirus disease 2019 disorder Efficacy event excluded finding FIVE five group foundation funding generally mild group healthy control healthy controls Hematopoietic stem cell highlight HIV HIV, Human immunodeficiency virus HSCT, Allogeneic hematopoietic stem cell transplantation Human immunodeficiency virus human stem-cell transplantation Ibrutinib Immunity Immunocompromised Immunocompromised patient immunocompromised patient group Immunocompromised patients immunodeficiency disorder immunodeficiency disorders IMPROVE Infection ITT, Intention to treat Knut leukemia Lymphocytic leukemia mPP, Modified per protocol mRNA BNT162b2 vaccine mRNA vaccination mycophenolate mycophenolate mofetil occurred of BNT162b2 Open-label organ transplantation organization organizations Patient patient group patient groups PID, Primary immunodeficiency disorders PP, Per protocol primary endpoint Primary Immunodeficiency Prospective clinical trial Rate Region Safe Safety SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2 second dose secondary endpoint Secondary endpoints selected serious adverse reaction Seroconversion seroconversion rate seroconverted solid organ solid organ transplantation SOT SOT, Solid organ transplantation stem cell subgroups subject Swedish T cell therapy Treatment vaccination against COVID-19 vaccine dose virus infection
[DOI] 10.1016/j.ebiom.2021.103705 PMC 바로가기 [Article Type] Research paper

Clinical characteristics and prognosis of immunosuppressed inpatients with COVID-19 in Japan

Observational Study

Published on 2021-10-282023-06-17
Journal: Journal of infection and chemotherapy : official j [Category] COVID19(2023년), MERS, SARS,

[키워드] ARDS, acute respiratory distress syndrome CI, Confidence interval COVID-19 COVID-19, coronavirus disease DMARDs, Disease-modifying anti-rheumatic drugs ECMO, extracorporeal membranous oxygenation HIV, Human immunodeficiency virus Immunosuppressed IMV, invasive mechanical ventilation IQR, interquartile range OR, odds ratio Prognosis SARS-CoV-2 SpO₂, oxygen saturation
[DOI] 10.1016/j.jiac.2021.10.021 PMC 바로가기 [Article Type] Observational Study

Immune recovery folliculitis: Case reports in HIV naïve and experienced patients

Article

Published on 2021-10-282024-09-04
Journal: IDCases [Category] 대상포진,

Untapping host-targeting cross-protective efficacy of anticoagulants against SARS-CoV-2

Review

Published on 2021-10-282023-07-01
Journal: Pharmacology & therapeutics [Category] COVID19(2023년), SARS,

[키워드] ACE2, angiotensin-converting enzyme 2 Ang II, Angiotensin II Anti-inflammatory Anticoagulant Antiviral AT1, angiotensin II type 1 receptor COPD, Chronic obstructive pulmonary disease coronavirus CoV, coronaviruses COVID-19, Coronavirus disease 2019 Drug repurposing FasL, Fas ligand HIV, Human immunodeficiency virus Host-targeting therapies IL1B, interleukin 1B IL6, Interleukin 6 M^pro, virally encoded main protease of SARS-CoV-2 MERS-CoV, Middle East respiratory syndrome coronavirus MSC, mesenchymal stem cell Nafamostat mesylate Nrf2, nuclear factor erythroid 2 p45-related factor 2 PD-L1, Programmed death-ligand 1 RdRp, RNA dependent RNA polymerase SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2 SARS-CoV, severe acute respiratory syndrome coronavirus TTSP, type II transmembrane serine protease VSV, Vesicular stomatitis virus
[DOI] 10.1016/j.pharmthera.2021.108027 PMC 바로가기 [Article Type] Review